• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GnRH拮抗剂方案中HCG扳机时机判定标准的新视角

New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles.

作者信息

Hu Xiaokun, Luo Yingyi, Huang Kejun, Li Yubing, Xu Yanwen, Zhou Canquan, Mai Qingyun

机构信息

From the Reproductive Medicine Center, The First Affiliated Hospital of Sun Yat-sen University, Guangdong, China.

出版信息

Medicine (Baltimore). 2016 May;95(20):e3691. doi: 10.1097/MD.0000000000003691.

DOI:10.1097/MD.0000000000003691
PMID:27196479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4902421/
Abstract

The aim of this study was to investigate 2 quantification criteria to evaluate the developmental condition of follicles cohort and clarify their impacts upon the determining of human chorionic gonadotropin trigger timing and the reproductive outcome: the proportion of mature follicles in growing follicles cohort on the day of human chorionic gonadotropin trigger and the peak estradiol level per oocyte on the day of human chorionic gonadotropin administration.Of the patients who underwent in vitro fertilization/ intracytoplasmic sperm injection-embryo transfer from 2011 to 2013, 492 controlled ovarian hyperstimulation cycles using gonadotropin-releasing hormone antagonists reaching the ovum pick-up and fresh embryo-transfer stage were included. Patients were divided into 3 groups according to their ≥17 mm/≥10 mm follicles ratio on the day of human chorionic gonadotropin administration (Low proportion: ≤30%, Middle proportion: 30%-60%, High proportion: ≥60%). Patients were divided into 5 groups according to their peak estradiol level/oocyte (Group A: <100 pg/mL per oocyte, Group B: 100-199 pg/mL per oocyte, Group C: 200-299 pg/mL per oocyte, Group D: 300-399 pg/mL per oocyte, Group E ≥400 pg/mL per oocyte) as well. Comparison among groups was made regarding ovarian stimulation characteristics, fertilization rate, good quality embryo rate, implantation, pregnancy, and live birth rates.On the basis of ≥17 mm/≥10 mm follicles ratio, the number of oocyte retrieved in low proportion group is more than other 2 groups. Implantation rate, clinical pregnancy, and live birth rate in high proportion group were 25.8%, 42.7%, and 31.1%, respectively, which is highest in 3 groups, and statistical significance existed between high and middle proportion groups. When the division is based on peak estradiol level/oocyte, the number of oocyte retrieved of ≥400 pg/mL per oocyte Group was significantly lowest compared with the other 4 groups. Matured ovum rate, fertilization rate, and good quality embryos rate exhibited an increasing trend as the peak estradiol level/oocyte increased. While pregnancy rate, implantation rate, and live birth rate were found to be lower whenever estradiol/oocyte ratio exceeded 400 pg/mL per oocyte or less than 100 pg/mL per oocyte, and there is statistical difference.Patients with the proportion of mature follicle reaching 60% on the day of human chorionic gonadotropin trigger and peak estradiol/oocyte level within 100∼399 pg/mL range can get a better pregnancy and implantation rate.

摘要

本研究旨在探讨2种量化标准,以评估卵泡群的发育状况,并阐明它们对人绒毛膜促性腺激素扳机时机的确定及生殖结局的影响:人绒毛膜促性腺激素扳机日生长卵泡群中成熟卵泡的比例,以及人绒毛膜促性腺激素给药日每个卵母细胞的雌二醇峰值水平。纳入2011年至2013年接受体外受精/卵胞浆内单精子注射-胚胎移植的患者,共492个使用促性腺激素释放激素拮抗剂且达到取卵和新鲜胚胎移植阶段的控制性卵巢刺激周期。根据人绒毛膜促性腺激素给药日≥17 mm/≥10 mm卵泡比例将患者分为3组(低比例组:≤30%,中比例组:30%-60%,高比例组:≥60%)。还根据每个卵母细胞的雌二醇峰值水平将患者分为5组(A组:每个卵母细胞<100 pg/mL,B组:每个卵母细胞100-199 pg/mL,C组:每个卵母细胞200-299 pg/mL,D组:每个卵母细胞300-399 pg/mL,E组:每个卵母细胞≥400 pg/mL)。比较各组的卵巢刺激特征、受精率、优质胚胎率、着床率、妊娠率和活产率。基于≥17 mm/≥10 mm卵泡比例,低比例组获取的卵母细胞数量多于其他2组。高比例组的着床率、临床妊娠率和活产率分别为25.8%、42.7%和31.1%,是3组中最高的,高比例组与中比例组之间存在统计学差异。当根据每个卵母细胞的雌二醇峰值水平进行分组时,每个卵母细胞≥400 pg/mL组获取的卵母细胞数量明显低于其他4组。随着每个卵母细胞的雌二醇峰值水平升高,成熟卵子率、受精率和优质胚胎率呈上升趋势。而当雌二醇/卵母细胞比例超过每个卵母细胞400 pg/mL或低于每个卵母细胞100 pg/mL时,妊娠率、着床率和活产率较低,且存在统计学差异。人绒毛膜促性腺激素扳机日成熟卵泡比例达到60%且每个卵母细胞的雌二醇峰值水平在100∼399 pg/mL范围内的患者可获得较好的妊娠和着床率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/4902421/5cd199bba559/medi-95-e3691-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/4902421/eff04f736bff/medi-95-e3691-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/4902421/5cd199bba559/medi-95-e3691-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/4902421/eff04f736bff/medi-95-e3691-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e9/4902421/5cd199bba559/medi-95-e3691-g005.jpg

相似文献

1
New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles.GnRH拮抗剂方案中HCG扳机时机判定标准的新视角
Medicine (Baltimore). 2016 May;95(20):e3691. doi: 10.1097/MD.0000000000003691.
2
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.促性腺激素释放激素激动剂和人绒毛膜促性腺激素双重触发可显著提高 GnRH 拮抗剂周期中正常反应者的活产率。
Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28.
3
The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.雌二醇/卵泡比值和雌二醇/卵母细胞比值对体外受精控制性卵巢刺激结局的影响。
Gynecol Endocrinol. 2007 Feb;23(2):72-5. doi: 10.1080/09513590601137137.
4
Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve.双重触发:促性腺激素释放激素激动剂联合人绒毛膜促性腺激素显著提高卵巢储备功能减退患者的活产率。
Reprod Biol Endocrinol. 2019 Jan 4;17(1):7. doi: 10.1186/s12958-018-0451-x.
5
Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF/ICSI cycles.促性腺激素释放激素激动剂和人绒毛膜促性腺激素(双重扳机)联合应用于 IVF/ICSI 周期可增加患者的优质胚胎数量。
J Ovarian Res. 2024 Jul 3;17(1):137. doi: 10.1186/s13048-024-01465-6.
6
Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial.双重触发使用重组人绒毛膜促性腺激素和促性腺激素释放激素激动剂改善 GnRH 拮抗剂周期中正常反应者的卵母细胞成熟和胚胎分级:随机对照试验。
J Gynecol Obstet Hum Reprod. 2020 May;49(5):101728. doi: 10.1016/j.jogoh.2020.101728. Epub 2020 Mar 12.
7
Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.孕酮/雌二醇比值对接受促性腺激素释放激素拮抗剂卵胞浆内单精子注射周期且扳机日孕酮水平高的患者妊娠结局的影响:一项回顾性队列研究
J Obstet Gynaecol. 2019 Feb;39(2):157-163. doi: 10.1080/01443615.2018.1504204. Epub 2018 Oct 3.
8
[Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].[每个取卵周期的累积活产率:体外受精/卵胞浆内单精子注射临床结局评估]
Zhonghua Fu Chan Ke Za Zhi. 2018 Mar 25;53(3):160-166. doi: 10.3760/cma.j.issn.0529-567X.2018.03.004.
9
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.在拮抗剂辅助生殖技术周期中,促性腺激素释放激素激动剂与绒毛膜促性腺激素用于触发卵母细胞的比较。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD008046. doi: 10.1002/14651858.CD008046.pub3.
10
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.促性腺激素释放激素拮抗剂的使用与排卵诱导-宫腔内人工授精向体外受精的转化率增加相关,与人绒毛膜促性腺激素给药日的年龄和雌二醇水平无关。
Fertil Steril. 2010 Feb;93(2):605-8. doi: 10.1016/j.fertnstert.2009.01.109. Epub 2009 Mar 26.

引用本文的文献

1
From patient classification to optimized treatment in ART: the AMPLITUDE Delphi consensus.从患者分类到抗逆转录病毒治疗的优化:AMPLITUDE德尔菲共识。
Front Reprod Health. 2024 Sep 27;6:1467322. doi: 10.3389/frph.2024.1467322. eCollection 2024.
2
Increasing dominant follicular proportion was associated with adverse IVF/ICSI outcomes in low-prognosis women undergoing GnRH antagonist protocol: a retrospective cohort study.在接受 GnRH 拮抗剂方案的低预后女性中,优势卵泡比例增加与 IVF/ICSI 不良结局相关:一项回顾性队列研究。
J Ovarian Res. 2024 Aug 31;17(1):179. doi: 10.1186/s13048-024-01502-4.
3
Two-dimensional ultrasound results in underestimation of the ovarian follicle size compared to automated three-dimensional imaging in women undergoing IVF.

本文引用的文献

1
Clinical Considerations of Preimplantation Genetic Diagnosis for Monogenic Diseases.单基因疾病胚胎植入前基因诊断的临床考量
PLoS One. 2015 Sep 30;10(9):e0139613. doi: 10.1371/journal.pone.0139613. eCollection 2015.
2
Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial.在使用促性腺激素释放激素(GnRH)拮抗剂的体外受精(IVF)方案中,人绒毛膜促性腺激素(hCG)给药时机的随机对照试验。
Hum Fertil (Camb). 2012 Sep;15(3):134-9. doi: 10.3109/14647273.2012.712739.
3
The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles.
在接受体外受精的女性中,与自动三维成像相比,二维超声会低估卵巢卵泡大小。
J Ultrasound. 2025 Mar;28(1):27-33. doi: 10.1007/s40477-023-00797-1. Epub 2023 Jun 23.
4
Increasing dominant follicular proportion negatively associated with good clinical outcomes in normal ovarian responders using the depot GnRH agonist protocol: a large-sample retrospective analysis.在使用长效 GnRH 激动剂方案的正常卵巢反应者中,优势卵泡比例增加与良好的临床结局呈负相关:一项大样本回顾性分析。
J Ovarian Res. 2022 Apr 13;15(1):44. doi: 10.1186/s13048-022-00973-7.
5
A Higher Estradiol Rise After Dual Trigger in Progestin-Primed Ovarian Stimulation Is Associated With a Lower Oocyte and Mature Oocyte Yield in Normal Responders.在孕激素预处理的卵巢刺激中,双重扳机后雌二醇升高幅度更大与正常反应者较低的卵母细胞和成熟卵母细胞产量相关。
Front Endocrinol (Lausanne). 2019 Oct 9;10:696. doi: 10.3389/fendo.2019.00696. eCollection 2019.
6
Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer.多囊卵巢综合征患者行体外受精-胚胎移植中主导卵泡比例的作用。
Chin Med J (Engl). 2019 Jun 20;132(12):1448-1453. doi: 10.1097/CM9.0000000000000246.
7
Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.在体外受精治疗中诱导卵母细胞最终成熟的新概念。
Endocr Rev. 2018 Oct 1;39(5):593-628. doi: 10.1210/er.2017-00236.
8
Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte.触发日的卵泡大小最有可能产生成熟卵母细胞。
Front Endocrinol (Lausanne). 2018 Apr 25;9:193. doi: 10.3389/fendo.2018.00193. eCollection 2018.
9
Low estradiol responses in oocyte donors undergoing gonadotropin stimulation do not influence clinical outcomes.促性腺激素刺激的卵母细胞供体中低雌二醇反应并不影响临床结局。
J Assist Reprod Genet. 2018 Sep;35(9):1675-1682. doi: 10.1007/s10815-018-1192-7. Epub 2018 Apr 27.
10
The effect of 24 hours delay in oocyte maturation triggering in IVF/ICSI cycles with antagonist protocol and not-elevated progesterone: A randomized control trial.在拮抗剂方案且孕酮未升高的体外受精/卵胞浆内单精子注射周期中,卵母细胞成熟触发延迟24小时的效果:一项随机对照试验。
Int J Reprod Biomed. 2017 Jul;15(7):441-446.
在促性腺激素释放激素拮抗剂/重组促卵泡生成素刺激周期中,孕激素过早升高与血清雌二醇水平及卵泡数量的关系。
Eur J Obstet Gynecol Reprod Biol. 2012 Jun;162(2):165-8. doi: 10.1016/j.ejogrb.2012.02.025. Epub 2012 Mar 17.
4
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.用于辅助生殖技术的促性腺激素释放激素拮抗剂
Cochrane Database Syst Rev. 2011 May 11(5):CD001750. doi: 10.1002/14651858.CD001750.pub3.
5
GnRH antagonists and endometrial receptivity in oocyte recipients: a prospective randomized trial.促性腺激素释放激素拮抗剂与卵母细胞受者的子宫内膜容受性:一项前瞻性随机试验
Reprod Biomed Online. 2009 Feb;18(2):276-81. doi: 10.1016/s1472-6483(10)60266-0.
6
Are GnRH antagonists comparable to agonists for use in IVF?促性腺激素释放激素(GnRH)拮抗剂在体外受精(IVF)中的应用与激动剂相当吗?
Hum Reprod. 2007 Nov;22(11):2805-13. doi: 10.1093/humrep/dem270. Epub 2007 Sep 14.
7
The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.雌二醇/卵泡比值和雌二醇/卵母细胞比值对体外受精控制性卵巢刺激结局的影响。
Gynecol Endocrinol. 2007 Feb;23(2):72-5. doi: 10.1080/09513590601137137.
8
Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.在体外受精中,卵泡期延长会导致使用重组促卵泡激素和促性腺激素释放激素拮抗剂刺激的周期中持续妊娠率降低。
Fertil Steril. 2004 Jul;82(1):102-7. doi: 10.1016/j.fertnstert.2004.01.027.
9
State of the art in in-vitro oocyte maturation.体外卵母细胞成熟的技术现状
Curr Opin Obstet Gynecol. 2004 Jun;16(3):211-9. doi: 10.1097/00001703-200406000-00003.
10
GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles.促性腺激素释放激素拮抗剂随后血清雌二醇水平下降会导致供卵周期出现不良结局。
Hum Reprod. 2003 Oct;18(10):2048-51. doi: 10.1093/humrep/deg407.